What is Yield10 Bioscience?
Yield10 Bioscience is an agricultural bioscience innovator headquartered in Woburn, Massachusetts, dedicated to the development of high-yield crop technologies. At the core of its operations is the GRAIN (Gene Ranking Artificial Intelligence Network) platform, a sophisticated tool designed to identify specific gene targets that improve yield performance and nutritional value in essential commercial food and feed crops. By utilizing the Camelina oilseed platform as a rapid testing vehicle, Yield10 effectively streamlines the translation of complex genetic traits into viable, field-tested solutions for the global agricultural market. The company's focus on sustainable food security positions it as a vital contributor to the future of industrial agriculture, addressing the growing demand for efficient, high-output crop production in an era of climate volatility.
How much funding has Yield10 Bioscience raised?
Yield10 Bioscience has raised a total of $119.5M across 4 funding rounds:
Stock Offering
$95.2M
Share Placement
$11.5M
Debt
$150K
Stock Offering
$12.7M
Stock Issuance/Offering (2006): $95.2M, investors not publicly disclosed
Share Placement (2019): $11.5M led by Jack W. Schuler
Debt (2020): $150K supported by PPP
Stock Issuance/Offering (2021): $12.7M, investors not publicly disclosed
Key Investors in Yield10 Bioscience
Jack W. Schuler
A prominent private investor and former executive known for his strategic focus on life sciences and medical technology ventures.
PPP
Public-Private Partnership
Undisclosed Institutional Backer
An institutional investor participating in the company's equity financing rounds to support long-term agricultural innovation.
What's next for Yield10 Bioscience?
With the recent influx of capital, Yield10 Bioscience is poised to scale its field testing and commercialization efforts significantly. The strategic roadmap involves deepening the integration of its GRAIN platform to identify new trait leads while simultaneously expanding the footprint of its Camelina oilseed platform. Investors are closely monitoring the company's ability to translate these genetic advancements into tangible market share within the global seed and crop protection industry. As the firm moves into this next phase of growth, the focus will likely shift toward securing long-term partnerships with major agricultural distributors and scaling production capabilities to meet the demands of a global food supply chain that is increasingly reliant on precision biotechnology.
See full Yield10 Bioscience company page
